Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 05, 2004 06:30 ET | Source: Tekron, Inc.

Tekron Inc. to Reward Shareholders with Dividend

FORT LAUDERDALE, Fla., May 5, 2004 (PRIMEZONE) -- Tekron Inc. (OTCBB:TKRN) has authorized a one time dividend of 10% to be issued in the form of unregistered stock Rule 144 to all shareholders of...
April 28, 2004 06:30 ET | Source: Tekron, Inc.

Tekron, Inc. Announces a $10.5 Million Private Placement

FORT LAUDERDALE, Fla., April 28, 2004 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) today announced that it will offer a US $10.5 million private placement offering of 10,000,000 units at a price of $0.30...
April 27, 2004 06:30 ET | Source: Tekron, Inc.

Tekron Inc. Acquires Bioenergy

FORT LAUDERDALE, Fla., April 27, 2004 (PRIMEZONE) -- Tekron Inc. (OTCBB:TKRN) is pleased to announce the acquisition of a 50% capital interest in Bioenergy. Bioenergy is an Italian corporation...
November 20, 2003 06:30 ET | Source: Tekron, Inc.

Tekron Inc. Announces the Application of the Biovirus Technology Platform to SARS

FT. LAUDERDALE, Fla., November 20, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) announces that in light of the current SARS concern in China, Biovirus is proceeding to immediately develop a putative...
November 20, 2003 06:30 ET | Source: Tekron, Inc.

Tekron Inc. Announces the Military Applications of the Technology Platform of Biovirus Medical

FT. LAUDERDALE, Fla., Nov. 20, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) announces that Biovirus and Dr. Insell are proceeding with the development of military applications of their combined...
November 18, 2003 08:20 ET | Source: Tekron, Inc.

Tekron Inc. Announces the Military Applications of the Technology Platform of Biovirus Medical

FT. LAUDERDALE, Fla., Nov. 18, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) announces that Biovirus and Dr. Insell are proceeding with the development of military applications of their combined...
November 13, 2003 06:30 ET | Source: Tekron, Inc.

Tekron, Inc. Announces Partnering of the Technology of Biovirus to Advance the Genomic Computational Analysis Platform

FT. LAUDERDALE, Fla., Nov. 13, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) is proceeding to partner and negotiate licensing for the products and technology platform of Biovirus. Biovirus is using...
November 11, 2003 06:30 ET | Source: Tekron, Inc.

Tekron, Inc. Announces Application for a $30 million grant to Advance Herpetic Vaccines Against Herpes Simplex I and II, Marak's Disease, SARS and West Nile Virus

FT. LAUDERDALE, Fla., Nov. 11, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) is undertaking its due diligence of Biovirus, which is proceeding forthwith. It is expected that the deal with Biovirus...
November 06, 2003 06:30 ET | Source: Tekron, Inc.

Tekron Inc. Rounds Out Corporate Team for Continued Growth and Expansion with New Director Of Marketing

FORT LAUDERDALE, Fla., Nov. 6, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN)) announces that it has hired Steven J. Weiss as the new Director of Marketing. Mr. Weiss has vast experience in online and...
November 05, 2003 07:00 ET | Source: Tekron, Inc.

Tekron, Inc. Announces Entrance into $300 Million Annual Market with the Acquisition of a Minority Interest -- 25% -- of Biovirus, which has Developed a Herpetic Vaccine Against Herpes Simplex I and II

FT. LAUDERDALE, Fla., Nov. 5, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) has inked an agreement with Biovirus, a privately held biotechnology company that has developed both a prophylactic vaccine...